Bottom line
What does SBIO hold?
SBIO held 89 positions as of May 31, 2026. Its largest holding is Alkermes Plc at 4.48% of the fund, and the top 10 positions add up to 34.8%. By asset type it is 100% stocks.
Updated Jul 29, 2026
SBIO top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Alkermes Plc Alkermes PLC |
Stocks | 4.48% | $7.2M |
| 2 | Kymera Therapeutics Inc Kymera Therapeutics, Inc. |
Stocks | 4.23% | $6.9M |
| 3 | Celcuity Inc Celcuity, Inc. |
Stocks | 3.92% | $6.3M |
| 4 | Mirum Pharmaceuticals Inc Mirum Pharmaceuticals, Inc. |
Stocks | 3.90% | $6.3M |
| 5 | Spyre Therapeutics Inc Spyre Therapeutics, Inc. |
Stocks | 3.68% | $6.0M |
| 6 | Cg Oncology Inc CG oncology, Inc. |
Stocks | 3.35% | $5.4M |
| 7 | Apogee Therapeutics Inc Apogee Therapeutics, Inc. |
Stocks | 2.93% | $4.7M |
| 8 | Xenon Pharmaceuticals Inc Xenon Pharmaceuticals, Inc. |
Stocks | 2.90% | $4.7M |
| 9 | Travere Therapeutics Inc Travere Therapeutics, Inc. |
Stocks | 2.77% | $4.5M |
| 10 | Dianthus Therapeutics Inc Dianthus Therapeutics, Inc. |
Stocks | 2.64% | $4.3M |
| 11 | Newamsterdam Pharma Co Nv Newamsterdam Pharma Co. NV |
Stocks | 2.47% | $4.0M |
| 12 | Viking Therapeutics Inc Viking Therapeutics, Inc. |
Stocks | 2.41% | $3.9M |
| 13 | Crinetics Pharmaceuticals Inc Crinetics Pharmaceuticals, Inc. |
Stocks | 2.37% | $3.8M |
| 14 | Acadia Pharmaceuticals Inc ACADIA Pharmaceuticals, Inc. |
Stocks | 2.35% | $3.8M |
| 15 | Edgewise Therapeutics Inc Edgewise Therapeutics, Inc. |
Stocks | 2.33% | $3.8M |
| 16 | Denali Therapeutics Inc Denali Therapeutics, Inc. |
Stocks | 2.13% | $3.4M |
| 17 | Oruka Therapeutics Inc Oruka Therapeutics, Inc. |
Stocks | 1.81% | $2.9M |
| 18 | Structure Therapeutics Inc Structure Therapeutics, Inc. |
Stocks | 1.78% | $2.9M |
| 19 | Disc Medicine Inc Disc Medicine, Inc. |
Stocks | 1.69% | $2.7M |
| 20 | Ideaya Biosciences Inc Ideaya Biosciences, Inc. |
Stocks | 1.65% | $2.7M |
| 21 | Vera Therapeutics Inc Vera Therapeutics, Inc. |
Stocks | 1.61% | $2.6M |
| 22 | Tarsus Pharmaceuticals Inc Tarsus Pharmaceuticals, Inc. |
Stocks | 1.61% | $2.6M |
| 23 | Relay Therapeutics Inc Relay Therapeutics, Inc. |
Stocks | 1.60% | $2.6M |
| 24 | Mineralys Therapeutics Inc Mineralys Therapeutics, Inc. |
Stocks | 1.59% | $2.6M |
| 25 | Celldex Therapeutics Inc Celldex Therapeutics, Inc. |
Stocks | 1.33% | $2.2M |
Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 29, 2026